Chemomab Therapeutics Ltd. Prepaid Expense and Other Assets, Current
Chemomab Therapeutics Ltd. (CMMB) had Prepaid Expense and Other Assets, Current of $3.06 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-03-23
- 2025-12-31: Prepaid Expense and Other Assets, Current $3.06M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $1.10M.
- 2024-12-31: Prepaid Expense and Other Assets, Current $1.70M.
- 2024-06-30: Prepaid Expense and Other Assets, Current $654.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $3.06M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $1.10M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $1.70M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $654.00K 6-K · filed 2024-08-21 | |
| 2023-12-31 | $1.04M 20-F · filed 2025-04-04 | |
| 2023-06-30 | $1.04M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $995.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.77M 20-F · filed 2024-03-28 | |
| 2022-09-30 | $2.26M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.11M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.93M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.53M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $1.57M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.92M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $320.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $141.00K 10-K · filed 2022-03-30 | $724.00K 10-K · filed 2021-03-09 |
| 2020-09-30 | $620.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $848.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $542.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $636.00K 10-K · filed 2021-03-09 |